CytRx Corporation (CYTR)’s Tamibarotene Continues to Protect Touring Professional Musician and Former NBA Player Ray Johnston From Leukemia
7/17/2012 10:11:34 AM
LOS ANGELES--(BUSINESS WIRE)--For more than two years, former Dallas Maverick basketball player Ray Johnston has been cancer-free. His advanced, highly aggressive acute promyelocytic leukemia (APL) was totally eradicated in 2010, just four months after beginning treatment with CytRx Corporation’s (NASDAQ:CYTR) cancer drug candidate tamibarotene. Since then, Mr. Johnston has continued taking tamibarotene tablets every other month to guard against a relapse.
comments powered by